Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$4.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV◆ | 2.3M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | PBUY | 232,870 | $18.00 | $4.2M | +5.8% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 716,872 | — | — | +21.8% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 2.7M | — | — | +450.0% | Open the original filing on SEC.gov |
| Jan 12 | AKTS | Aktis Oncology, Inc. | CCONV | 597,391 | — | — | — | Open the original filing on SEC.gov |